Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nelson

Showing results (921-930 of 1,126) with videos related to

Pageof 113
Sort By:
Applied Clinical Informatics|September 1, 2016
Integrating Genomic Resources with Electronic Health Records using the HL7 Infobutton StandardBret S E Heale, Casey Lynnette Overby, Guilherme Del Fiol, et al.
Cancer Research|June 16, 2011
A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiationVictor W Ho, Kelvin Leung, Anderson Hsu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United StatesAnala Gossai, Tim Waterboer, Heather H Nelson, et al.
Epigenetics|July 22, 2011
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesotheliomaHeather H Nelson, Lindsay M Almquist, Jessica L LaRocca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Nature Communications|December 8, 2017
Human CD26<sup>high</sup> T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistenceStefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, et al.
Pigment Cell & Melanoma Research|August 14, 2023
Melanoma literacy among the general population of three western US statesSancy A Leachman, Emile Latour, Brian Detweiler-Bedell, et al.
Cancer Treatment and Research Communications|June 1, 2026
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)Helen J MacKay, Anna V Tinker, Brad H Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2021
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal AdenocarcinomaDeepak Raj, Maria Nikolaidi, Irene Garces, et al.
Breast Cancer Research and Treatment|February 11, 2016
Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivorsSandahl H Nelson, Catherine R Marinac, Ruth E Patterson, et al.
Pageof 113

Showing results (921-930 of 1,126) with videos related to

Sort By:
Pageof 113
Applied Clinical Informatics|September 1, 2016
Integrating Genomic Resources with Electronic Health Records using the HL7 Infobutton StandardBret S E Heale, Casey Lynnette Overby, Guilherme Del Fiol, et al.
Cancer Research|June 16, 2011
A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiationVictor W Ho, Kelvin Leung, Anderson Hsu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United StatesAnala Gossai, Tim Waterboer, Heather H Nelson, et al.
Epigenetics|July 22, 2011
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesotheliomaHeather H Nelson, Lindsay M Almquist, Jessica L LaRocca, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2015
The inducible costimulator augments Tc17 cell responses to self and tumor tissueMichelle H Nelson, Sreenath Kundimi, Jacob S Bowers, et al.
Nature Communications|December 8, 2017
Human CD26<sup>high</sup> T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistenceStefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, et al.
Pigment Cell & Melanoma Research|August 14, 2023
Melanoma literacy among the general population of three western US statesSancy A Leachman, Emile Latour, Brian Detweiler-Bedell, et al.
Cancer Treatment and Research Communications|June 1, 2026
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)Helen J MacKay, Anna V Tinker, Brad H Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2021
CEACAM7 Is an Effective Target for CAR T-cell Therapy of Pancreatic Ductal AdenocarcinomaDeepak Raj, Maria Nikolaidi, Irene Garces, et al.
Breast Cancer Research and Treatment|February 11, 2016
Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivorsSandahl H Nelson, Catherine R Marinac, Ruth E Patterson, et al.
Pageof 113